Publications by authors named "Amy Goodrich"

Claim this Profile
T
The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment.
Edina Komlodi-Pasztor, Marta Escarra-Senmarti, Danielle A Bazer, Aastha Bhatnagar, Carlos A Perez Heydrich, Amy Goodrich

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel.
Anthony J Perissinotti, Michael R Bishop, Joseph Bubalo, Mark B Geyer, Amy Goodrich

Cancer Treat Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials.
Jacqueline Saunders, Sumati Murli, Michelle A Rudek, Anand Khandoobhai, Anne DeLisa, Amy Goodrich

J Hematol Oncol Pharm· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Practice Perspectives on Preventing and Managing Tumor Lysis Syndrome and Neutropenia in Chronic Lymphocytic Leukemia.
Amy Goodrich

J Adv Pract Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Outcomes for Patients With Chronic Lymphocytic Leukemia.
Mazyar Shadman, Amy Goodrich

J Adv Pract Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma Therapy and Adverse Events: Nursing Strategies for Thinking Critically and Acting Decisively.
Amy Goodrich, Nina Wagner-Johnston, Dana Delibovi

Clin J Oncol Nurs· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-Stratified Treatment in Chronic Lymphocytic Leukemia.
Deborah M Stephens, Amy L Goodrich

J Adv Pract Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine: a novel cytotoxic agent for hematologic malignancies.
Susan Blumel, Amy Goodrich, Cheryl Martin, Nam H Dang

Clin J Oncol Nurs· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutional duplication of a region of chromosome Yp encoding AMELY, PRKY, and TBL1Y: implications for sex chromosome analysis and bone marrow engraftment analysis.
Kathleen M Murphy, Julie S Cohen, Amy Goodrich, Patricia P Long, Constance A Griffin

J Mol Diagn· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
Amy Goodrich

Clin J Oncol Nurs· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Carl R Willis, Amy Goodrich, Kathy Park, Jamie K Waselenko, Margaret Lucas

Ann Hematol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis